UPS: this new facility sits at the heart of some of the fastest-growing healthcare markets in the world
UPS has opened its first dedicated Healthcare logistics facility in Ostrava, Czech Republic. The state-of-the-art and GDP compliant 3,800m2 facility houses multiple validated controlled-temperature environments for a variety of temperature-sensitive medicines and biologics.
Located in the heart of Central & Eastern Europe, the new facility offers access to the fast-growing Eastern European market, supporting pharmaceutical and medical device customers in the Czech Republic and providing another direct link from Europe to UPS’s global network. The facility will enable faster shipment times and greater flexibility for customers, as well as offering Hospital & Pharmacy Distribution across the Czech Republic and to Slovakia, Poland and Hungary.
“Connected to our global network, this new facility sits at the heart of some of the fastest-growing healthcare markets in the world. By expanding our capabilities in the region, and opening our first facility in the Czech Republic, we’re investing in our customers, whose latest pharmaceutical, biotech and medical device products require a range of specialist storage and handling services.” said Fredrik Jansson, Managing Director, Central & Eastern Europe, UPS Healthcare Europe.
Innovations in biologics, specialty pharmaceuticals and personalized medicine demand precision, temperature-controlled logistics to get patient-critical products where they need to be. The global market for biologic therapeutic drugs is set to increase from $285.5 billion in 2020 to $421.8 billion by 2025.
In 2021, UPS Healthcare invested in over 36,000m2 of cold chain GMP coolers and freezers in newly dedicated and upgraded healthcare facilities including in Italy, Poland, the Netherlands, Germany, the USA and Australia. Able to support the storage of biologics ranging from 2°C to as low as -80°C, these facilities are adding to the existing 1 million square meters of dedicated healthcare warehouse space across 32 countries.
UPS has delivered over 600 million COVID-19 vaccines in over 100 countries at 99.999% on-time delivery, and is on track to deliver at least one billion vaccines by the end of 2021.
UPS first began offering services to the Czech Republic in 1992 and currently employs approximately 500 people.